Showing results (2421-2430 of 2,890) with videos related to

Sort By:
Pageof 289
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 2019
Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancerA B Schrock, C Ouyang, J Sandhu, et al.
Nature Communications|January 23, 2021
Artemisinin-resistant K13 mutations rewire Plasmodium falciparum's intra-erythrocytic metabolic program to enhance survivalSachel Mok, Barbara H Stokes, Nina F Gnädig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2019
On-target Resistance to the Mutant-Selective EGFR Inhibitor Osimertinib Can Develop in an Allele-Specific Manner Dependent on the Original EGFR-Activating MutationBenjamin P Brown, Yun-Kai Zhang, David Westover, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2013
Relapsed classic E-cadherin (CDH1)-mutated invasive lobular breast cancer shows a high frequency of HER2 (ERBB2) gene mutationsJeffrey S Ross, Kai Wang, Christine E Sheehan, et al.
Cancer Research|February 26, 2017
High-Throughput Genomic Profiling of Adult Solid Tumors Reveals Novel Insights into Cancer PathogenesisRyan J Hartmaier, Lee A Albacker, Juliann Chmielecki, et al.
Pigment Cell & Melanoma Research|November 25, 2017
BRAF internal deletions and resistance to BRAF/MEK inhibitor therapyDouglas B Johnson, Merrida A Childress, Zachary R Chalmers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Breast cancer molecular subtypes respond differently to preoperative chemotherapyRoman Rouzier, Charles M Perou, W Fraser Symmans, et al.
Perfusion|May 28, 2004
Highest core temperature during cardiopulmonary bypass and rate of mediastinitisRobert C Groom, Athos J Rassias, John E Cormack, et al.
Oncoscience|August 6, 2015
Durable clinical benefit to trastuzumab and chemotherapy in a patient with metastatic colon adenocarcinoma harboring ERBB2 amplificationUmut Disel, Alexis Germain, Bahar Yilmazel, et al.
JAMA Network Open|October 22, 2021
Real-world Cardiovascular Outcomes Associated With Degarelix vs Leuprolide for Prostate Cancer TreatmentJoshua D Wallach, Yihong Deng, Rozalina G McCoy, et al.
Pageof 289